RU2630586C2 - Повязка на кожу с электродами и предшественником физиологически активного вещества - Google Patents
Повязка на кожу с электродами и предшественником физиологически активного вещества Download PDFInfo
- Publication number
- RU2630586C2 RU2630586C2 RU2014142697A RU2014142697A RU2630586C2 RU 2630586 C2 RU2630586 C2 RU 2630586C2 RU 2014142697 A RU2014142697 A RU 2014142697A RU 2014142697 A RU2014142697 A RU 2014142697A RU 2630586 C2 RU2630586 C2 RU 2630586C2
- Authority
- RU
- Russia
- Prior art keywords
- skin
- electrodes
- electrode
- dressing according
- dressing
- Prior art date
Links
- 239000002243 precursor Substances 0.000 title claims abstract description 17
- 239000013543 active substance Substances 0.000 title claims abstract description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 24
- 239000000126 substance Substances 0.000 claims abstract description 11
- 238000006056 electrooxidation reaction Methods 0.000 claims abstract description 5
- 239000000017 hydrogel Substances 0.000 claims description 33
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 15
- 229910052799 carbon Inorganic materials 0.000 claims description 14
- 230000000845 anti-microbial effect Effects 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000009792 diffusion process Methods 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 239000006260 foam Substances 0.000 claims description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 45
- 229910052740 iodine Inorganic materials 0.000 description 45
- 239000011630 iodine Substances 0.000 description 45
- 239000000499 gel Substances 0.000 description 26
- 206010052428 Wound Diseases 0.000 description 20
- 208000027418 Wounds and injury Diseases 0.000 description 20
- 238000013461 design Methods 0.000 description 17
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 17
- 239000010410 layer Substances 0.000 description 17
- 239000000463 material Substances 0.000 description 15
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- -1 iodide ions Chemical class 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000004599 antimicrobial Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 229920001477 hydrophilic polymer Polymers 0.000 description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 3
- 239000002861 polymer material Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000007650 screen-printing Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 2
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000000970 chrono-amperometry Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000007933 dermal patch Substances 0.000 description 2
- 238000003487 electrochemical reaction Methods 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 125000005385 peroxodisulfate group Chemical group 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- CHAGFXOGGUIYIM-UHFFFAOYSA-N (2-cyclohexyl-3-hydroxyphenyl)-phenylmethanone Chemical compound Oc1cccc(C(=O)c2ccccc2)c1C1CCCCC1 CHAGFXOGGUIYIM-UHFFFAOYSA-N 0.000 description 1
- BHWMZEPWQUFLLQ-UHFFFAOYSA-N 2-hydroxypropanoic acid;zinc Chemical compound [Zn].CC(O)C(O)=O BHWMZEPWQUFLLQ-UHFFFAOYSA-N 0.000 description 1
- KPYCVQASEGGKEG-UHFFFAOYSA-N 3-hydroxyoxolane-2,5-dione Chemical compound OC1CC(=O)OC1=O KPYCVQASEGGKEG-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 238000004082 amperometric method Methods 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- GTKRFUAGOKINCA-UHFFFAOYSA-M chlorosilver;silver Chemical compound [Ag].[Ag]Cl GTKRFUAGOKINCA-UHFFFAOYSA-M 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 125000004386 diacrylate group Chemical group 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000013138 pruning Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- WRTMQOHKMFDUKX-UHFFFAOYSA-N triiodide Chemical group I[I-]I WRTMQOHKMFDUKX-UHFFFAOYSA-N 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0432—Anode and cathode
- A61N1/0436—Material of the electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0432—Anode and cathode
- A61N1/044—Shape of the electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0468—Specially adapted for promoting wound healing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0492—Patch electrodes
- A61N1/0496—Patch electrodes characterised by using specific chemical compositions, e.g. hydrogel compositions, adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1205120.7 | 2012-03-23 | ||
| GBGB1205120.7A GB201205120D0 (en) | 2012-03-23 | 2012-03-23 | Skin dressing |
| GB1209820.8 | 2012-06-01 | ||
| GBGB1209820.8A GB201209820D0 (en) | 2012-06-01 | 2012-06-01 | Skin dressing |
| PCT/GB2013/050741 WO2013140176A1 (en) | 2012-03-23 | 2013-03-21 | Skin dressing with electrodes and physiologically active precursor substance |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2014142697A RU2014142697A (ru) | 2016-05-20 |
| RU2630586C2 true RU2630586C2 (ru) | 2017-09-11 |
Family
ID=48444422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014142697A RU2630586C2 (ru) | 2012-03-23 | 2013-03-21 | Повязка на кожу с электродами и предшественником физиологически активного вещества |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9717891B2 (enExample) |
| EP (1) | EP2827940A1 (enExample) |
| JP (1) | JP6203245B2 (enExample) |
| KR (1) | KR20140140597A (enExample) |
| CN (1) | CN104284695A (enExample) |
| AU (1) | AU2013237171B2 (enExample) |
| BR (1) | BR112014023295A2 (enExample) |
| CA (1) | CA2863299A1 (enExample) |
| RU (1) | RU2630586C2 (enExample) |
| WO (1) | WO2013140176A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2524777A (en) * | 2014-04-02 | 2015-10-07 | Microarray Ltd | Dressing comprising electrodes |
| EP3322451B1 (en) * | 2015-07-14 | 2021-03-24 | Washington State University | Electrochemical reduction or prevention of infections |
| US10913936B2 (en) | 2016-03-22 | 2021-02-09 | California Institute Of Technology | Phenazine degrading agents and related compositions, methods and systems for interfering with viability of bacteria |
| GB201608315D0 (en) * | 2016-05-12 | 2016-06-29 | Grafmed | Device for delivering medicaments or active ingredients |
| US11197991B2 (en) * | 2016-06-27 | 2021-12-14 | Sekisui Plastics Co., Ltd. | Gel sheet |
| US20190275191A1 (en) * | 2016-10-19 | 2019-09-12 | 3M Innovative Properties Company | Anti-microbial articles |
| CN107095738A (zh) * | 2017-05-31 | 2017-08-29 | 西人马（厦门）科技有限公司 | 电子绷带 |
| CN107440835A (zh) * | 2017-09-07 | 2017-12-08 | 河南汇博医疗股份有限公司 | 一种微电流护创敷料 |
| DE102017123809B4 (de) * | 2017-10-12 | 2025-10-30 | Swiss Spa System Ltd. | In einer Hand haltbares Gerät zur elektrisch unterstützten Hautbehandlung, Zusatzteil für dieses Gerät und Blister für dieses Zusatzteil |
| JP6964235B2 (ja) * | 2018-01-17 | 2021-11-10 | パナソニックＩｐマネジメント株式会社 | 薬剤浸透装置 |
| GB2577493A (en) * | 2018-09-25 | 2020-04-01 | Sumitomo Chemical Co | Wound dressing |
| EP3847986A1 (de) * | 2020-01-13 | 2021-07-14 | Erbe Elektromedizin GmbH | Neutralelektrode und verfahren zur ausbildung einer solchen |
| WO2022099024A1 (en) | 2020-11-05 | 2022-05-12 | California Institute Of Technology | Pyocyanine demethylases and related phenazine degrading agents compositions, methods and systems for interfering with viability of bacteria |
| US20250058002A1 (en) * | 2023-04-25 | 2025-02-20 | California Institute Of Technology | Electrochemical inhibition of redox active bacteria and related devices, methods and systems |
| CN122295147A (zh) * | 2023-11-27 | 2026-06-26 | 爱恩斯生物有限公司 | 伤口治疗用的电极贴片及利用高压脉冲电流电刺激的伤口治疗装置 |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6490482B2 (en) * | 1997-11-05 | 2002-12-03 | Hisamitsu Pharmaceutical Company, Inc. | Apparatus and method for in vivo delivery of therapeutic agents |
| US20030023297A1 (en) * | 2001-06-18 | 2003-01-30 | Byers Charles L. | Miniature implantable array and stimulation system suitable for eyelid stimulation |
| AU2005205797A1 (en) * | 2003-02-07 | 2005-09-29 | Woundel Health Care | Multi-layer combination of an electric stimulation electrode and a wound dressing |
| US20080004564A1 (en) * | 2006-03-30 | 2008-01-03 | Transcutaneous Technologies Inc. | Controlled release membrane and methods of use |
| RU2323017C2 (ru) * | 2001-10-24 | 2008-04-27 | Пауэр Пэйпер Лтд. | Устройство и способ контролируемой доставки активных веществ в кожу |
| WO2009158032A1 (en) * | 2008-06-25 | 2009-12-30 | Fe2, Inc. | Patches and methods for the transdermal delivery of a therapeutically effective amount of iron |
| WO2011099512A1 (ja) * | 2010-02-12 | 2011-08-18 | テルモ株式会社 | イオントフォレシス用パッチ |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL86076A (en) | 1988-04-14 | 1992-12-01 | Inventor S Funding Corp Ltd | Transdermal drug delivery device |
| US5578022A (en) | 1995-04-12 | 1996-11-26 | Scherson; Daniel A. | Oxygen producing bandage and method |
| EP1292628B1 (en) | 2000-06-15 | 2010-06-09 | First Water Limited | Process for the manufacture of hydrogel compositions and hydrogel compositions manufactured thereby |
| JP4475959B2 (ja) | 2002-04-24 | 2010-06-09 | インセンス・リミテッド | 水和ヒドロゲル類および酵素類を含む傷被覆材 |
| KR20050121277A (ko) | 2003-06-02 | 2005-12-26 | 파워 페이퍼 리미티드 | 피부 내로 산화제의 조절된 운반을 위한 키트, 디바이스 및그의 방법 |
| CA2525758A1 (en) | 2003-06-09 | 2004-12-16 | Insense Limited | Method for stabilization of enzymes during exposure to sterilizing radiation |
| GB0313217D0 (en) | 2003-06-09 | 2003-07-16 | Insense Ltd | Improvements in or relating to skin dressings |
| US20050181026A1 (en) | 2003-06-09 | 2005-08-18 | Insense Limited | Skin dressings |
| US7486989B2 (en) | 2003-06-30 | 2009-02-03 | Johnson & Johnson Consumer Companies, Inc. | Device for delivery of oxidizing agents to barrier membranes |
| GB0427444D0 (en) | 2004-01-30 | 2005-01-19 | Insense Ltd | Improvements relating to skin dressings |
| US7403807B2 (en) | 2004-07-27 | 2008-07-22 | Zoll Medical Corporation | Medical electrode with peripheral edge of conductor sealed from electrolyte |
| GB0505035D0 (en) | 2005-03-11 | 2005-04-20 | Insense Ltd | Improvements relating to skin dressings |
| JP4907135B2 (ja) | 2005-09-14 | 2012-03-28 | Ｔｔｉ・エルビュー株式会社 | イオントフォレーシス装置 |
| US20070112294A1 (en) | 2005-09-14 | 2007-05-17 | Transcutaneous Technologies Inc. | Iontophoresis device |
| CN101862505B (zh) * | 2010-07-15 | 2014-07-30 | 四川大学 | 自电渗水凝胶贴膜 |
-
2013
- 2013-03-21 CN CN201380015621.0A patent/CN104284695A/zh active Pending
- 2013-03-21 EP EP13722800.3A patent/EP2827940A1/en not_active Withdrawn
- 2013-03-21 US US14/383,284 patent/US9717891B2/en not_active Expired - Fee Related
- 2013-03-21 KR KR1020147029661A patent/KR20140140597A/ko not_active Ceased
- 2013-03-21 AU AU2013237171A patent/AU2013237171B2/en not_active Ceased
- 2013-03-21 CA CA2863299A patent/CA2863299A1/en not_active Abandoned
- 2013-03-21 WO PCT/GB2013/050741 patent/WO2013140176A1/en not_active Ceased
- 2013-03-21 JP JP2015500988A patent/JP6203245B2/ja not_active Expired - Fee Related
- 2013-03-21 RU RU2014142697A patent/RU2630586C2/ru not_active IP Right Cessation
- 2013-03-21 BR BR112014023295-4A patent/BR112014023295A2/pt not_active IP Right Cessation
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6490482B2 (en) * | 1997-11-05 | 2002-12-03 | Hisamitsu Pharmaceutical Company, Inc. | Apparatus and method for in vivo delivery of therapeutic agents |
| US20030023297A1 (en) * | 2001-06-18 | 2003-01-30 | Byers Charles L. | Miniature implantable array and stimulation system suitable for eyelid stimulation |
| RU2323017C2 (ru) * | 2001-10-24 | 2008-04-27 | Пауэр Пэйпер Лтд. | Устройство и способ контролируемой доставки активных веществ в кожу |
| AU2005205797A1 (en) * | 2003-02-07 | 2005-09-29 | Woundel Health Care | Multi-layer combination of an electric stimulation electrode and a wound dressing |
| US20080004564A1 (en) * | 2006-03-30 | 2008-01-03 | Transcutaneous Technologies Inc. | Controlled release membrane and methods of use |
| WO2009158032A1 (en) * | 2008-06-25 | 2009-12-30 | Fe2, Inc. | Patches and methods for the transdermal delivery of a therapeutically effective amount of iron |
| WO2011099512A1 (ja) * | 2010-02-12 | 2011-08-18 | テルモ株式会社 | イオントフォレシス用パッチ |
Also Published As
| Publication number | Publication date |
|---|---|
| US20150025479A1 (en) | 2015-01-22 |
| AU2013237171A1 (en) | 2014-09-18 |
| JP2015512283A (ja) | 2015-04-27 |
| KR20140140597A (ko) | 2014-12-09 |
| RU2014142697A (ru) | 2016-05-20 |
| JP6203245B2 (ja) | 2017-09-27 |
| AU2013237171B2 (en) | 2017-04-20 |
| EP2827940A1 (en) | 2015-01-28 |
| US9717891B2 (en) | 2017-08-01 |
| CA2863299A1 (en) | 2013-09-26 |
| CN104284695A (zh) | 2015-01-14 |
| WO2013140176A1 (en) | 2013-09-26 |
| BR112014023295A2 (pt) | 2020-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2013237171B2 (en) | Skin dressing with electrodes and physiologically active precursor substance | |
| CA2226176C (en) | Hydrogel patch | |
| CN101528276B (zh) | 过氧化氢递送系统 | |
| KR101506930B1 (ko) | 피부 드레싱에 관한 개선 | |
| JP4221151B2 (ja) | 電子搬送装置用の電気化学的反応性カソード | |
| US8706183B2 (en) | Electrode systems, devices and methods | |
| US20070190122A1 (en) | Skin dressings | |
| JPH07507465A (ja) | イオン導入薬物投与装置 | |
| US5234992A (en) | Electrotransport adhesive | |
| CN114366091A (zh) | 一种连续监测或检测体内分析物的微针贴片、其制备方法及相关装置 | |
| US20170020736A1 (en) | Dressing comprising electrodes | |
| WO2001013988A1 (en) | Devices and methods for the generation of voltage potential | |
| CN110772378A (zh) | 敷料 | |
| US20250345592A1 (en) | Biodegradable ion patch and method for manufacturing the same | |
| EP4691545A1 (en) | Transdermal current-carrying patch |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20190322 |